SpaceX IPO High Valuation Raises Questions Amid Hype and Achievement UK Police Chiefs Call for Blocking Unsafe Social Media for Under16s Potential Regulatory Pressure on Tech Giants UN Raises Ebola Risk Level to Very High in DR Congo Potential Implications for Regional Markets Microns New Milestone Dicks Earnings and Paxtons Victory Over Cornyn Lead CNBC Morning Squawk Retail Earnings Flood This Week as Dollar Tree Gap and AI Players Like Dell Report Technological Innovations Reshaping the Healthcare Landscape From Wearables to 3DPrinted Organs CheckCap Ltd MBAI Q3 2023 Earnings EPS Misses Estimates as PreRevenue Company Continues RD Efforts OABI Q1 2026 Earnings WiderthanExpected Loss Narrows as EPS Surprises Positively BOX Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction SCVL Q1 2026 Earnings Modest Miss on EPS Amid Challenging Retail Environment CYCN Q4 2025 Earnings Narrowed Loss Beats Street Estimates Shares Climb Mobile Infrastructure Corporation BEEP Q1 2026 Earnings Narrow EPS Beat Fails to Stem Stock Decline Onfolio Holdings Inc ONFO Edges Higher Testing Key Resistance at 071 Elutia Inc ELUT Dips 333 as Stock Hovers Near Critical 110 Support Pimco Corporate Income Opportunity Fund PTY Holds Steady Near Support Amid Modest Decline First United Corporation FUNC Slips 107 as Regional Bank Pressures Persist Phillips Edison Company PECO Holds Near Support After Modest Gain Microsoft Debuts GridSFM to Tackle 20 Billion Grid Congestion Challenge ATS Q1 2026 Earnings EPS Surpasses Estimates as Automation Demand Drives Profitability MREO Edges Higher Holding Near Support as Biotech Sector Watches Jim Cramers Vote of Confidence on Intuit INTU Preceded a Steep Decline Tesla Launches Full SelfDriving Supervised in China Amid Intensifying Competition BitMine Emerges as Candidate for Russell 1000 Index Inclusion Wingstop Shares Drop 12 as Profit Misses Market Expectations Wind Repowering A Potential Catalyst for Renewable Energy Growth Investors Shift Focus to Two Recent IPOs as SpaceX IPO Speculation Rises CVS Coverage for Lillys GLP1 Drugs Could Expand Market Access for Millions